Dow Jones futures tick up as Wall Street braces for retail sales, jobs and CPI

Dow Jones Industrial Average futures edged higher early Tuesday, pointing to a steady open after the blue-chip index set another closing record in the last session. Dow futures were up 45 points, or 0.09%, at 50,264 by 5:30 a.m. EST, while S&P 500 futures and Nasdaq 100 futures were also modestly higher.

10 February 2026

Merck stock slides 3.5% as insider sale filing lands; traders eye next FDA deadline

Merck & Co slipped $4.32, or 3.5%, to finish at $117.65 Monday. The stock barely budged in after-hours trading. During the session, shares swung between $116.99 and $122.12. Trading volume landed at roughly 16.2 million shares.

10 February 2026

NYSE:MRK·Stock Market

Amgen stock drops nearly 2% as Dow drag builds — what AMGN investors watch next

Amgen Inc was off 1.8% to $377.28 by mid-afternoon Monday, slipping from its $384.32 finish on Friday. Shares moved between $372.39 and $384.96 during the session.

9 February 2026

NASDAQ:AMGN·NASDAQ:HIMS·NASDAQ:NVO·NYSE:MRK·Stock Market

Merck stock drops nearly 4%: why MRK is lagging the market today

Merck & Co slipped 3.9% to $117.16 by the afternoon, trailing a market that managed slight gains. The S&P 500 and Nasdaq edged up, but health care stocks struggled.

9 February 2026

NYSE:MRK·Pharmaceuticals·Stock Market

Dow Jones Industrial Average slips under 50,000 as AI shakeout bites; payrolls, CPI loom

Dow Jones Industrial Average dropped 132.72 points, or 0.26%, to 49,982.95 in Monday morning trading, falling under the 50,000 mark again. S&P 500 edged down 0.08%. Nasdaq barely moved. The 10-year Treasury yield held steady near 4.24%.

9 February 2026

Artificial Intelligence·NASDAQ:AMGN·NYSE:MRK·Stock Market

Merck stock is inches from a 52-week high — and an insider just sold shares

Merck & Co, Inc. finished Friday’s session up 1.82% at $121.93, putting the stock less than half a percent under its 52-week high as U.S. equities broadly rallied. While Pfizer and Eli Lilly posted bigger moves, Merck outperformed Johnson & Johnson. Trading volume landed at roughly 13 million shares, trailing the 50-day average, MarketWatch data shows.

8 February 2026

NYSE:MRK·Pharmaceuticals·Stock Market

Merck stock ends week near highs after Canada clears ENFLONSIA; insider sales surface

Merck & Co., Inc. climbed 1.8% to close at $121.93 Friday, with the stock edging closer to its previous highs. The move followed news that Health Canada cleared the company’s ENFLONSIA RSV antibody for use in newborns and infants.

7 February 2026

NYSE:MRK·Pharmaceuticals·Stock Market

Merck (MRK) stock price rises as Enflonsia approval and insider filing keep attention on what’s next

Merck & Co. shares rose 1.8% to $121.92 on Friday, after trading as high as $122.65 earlier in the session. The stock had opened at $121.01.

6 February 2026

NYSE:MRK·Stock Market

Merck stock rises 2% in New York as MRK traders size up outlook and a fresh RSV approval

Shares of Merck & Co., Inc. climbed roughly 2% Thursday afternoon, hitting $120.72. The stock swung between $117.34 and $122.39, with volume near 12.8 million shares.

5 February 2026

NYSE:MRK·Pharmaceuticals·Stock Market

Merck stock rises after-hours as cautious 2026 forecast meets new cholesterol pill headlines

Merck & Co shares climbed roughly 2.2% in after-hours trading Wednesday, closing at $118.33, after hitting a peak of $120.36 during the session.

5 February 2026

Earnings Reports·NYSE:MRK·Pharmaceuticals·Stock Market

Merck stock price rises today as MRK rallies on Keytruda strength despite soft 2026 outlook

Merck & Co shares climbed roughly 2.8% to $119.11 by midday in New York on Wednesday, gaining $3.27 since Tuesday’s close. The stock’s intraday range has been between $115.79 and $119.93.

4 February 2026

NYSE:MRK·Pharmaceuticals·Stock Market

Merck stock price rises after hours after choppy day — MRK traders focus on 2026 outlook and FDA dates

Merck & Co shares climbed 2.2% in after-hours trading Tuesday, closing at $115.84. During the session, the stock fluctuated between $109.02 and $118.35.

4 February 2026

NYSE:MRK·Pharmaceuticals·Stock Market

Dow Jones slips 167 points on AI disruption fears; Alphabet, Amazon earnings next

The Dow Jones Industrial Average dropped 166.67 points Tuesday, closing down 0.34% at 49,240.99 as tech and software stocks came under pressure amid renewed worries about AI squeezing profit margins. “We’re seeing a lot of software companies across the spectrum get hit,” said Art Hogan, chief market strategist at B. Riley Wealth. The S&P 500 fell 0.84% to 6,917.81, while the Nasdaq slid 1.43% to 23,255.19. Merck bucked the trend, rising 2.2% after reporting results, and PepsiCo surged 4.9% following announcements of price cuts on brands like Lay’s and Doritos.

3 February 2026

Earnings Reports·NASDAQ:AMZN·NASDAQ:GOOGL·NASDAQ:NVDA·NYSE:CRM·NYSE:IBM·NYSE:MRK·NYSE:PEP·NYSE:TRI·NYSE:WMT·Stock Market·Technology

Merck stock rises despite cautious 2026 outlook as patent losses loom

Merck shares climbed around 3.1% to $116.86 in midday trading Tuesday, despite the drugmaker warning its 2026 outlook would fall short of Wall Street expectations due to patent expirations on older drugs.

3 February 2026

NYSE:MRK·Pharmaceuticals·Stock Market

Merck stock rises ahead of earnings: MRK traders eye guidance and the Keytruda cliff

Merck & Co shares climbed roughly 2.2% on Monday, pushing the price up to $112.67 by midday. During the session, the stock fluctuated between $109.80 and $112.74.

2 February 2026

Earnings Reports·NYSE:MRK·Pharmaceuticals·Stock Market

Merck stock price ends higher ahead of Feb. 3 earnings — what MRK investors watch next week

Merck shares climbed 1.8% on Friday, finishing at $110.27. Investors are bracing for this week’s update on sales and earnings from the drugmaker.

1 February 2026

Earnings Reports·NYSE:MRK·Pharmaceutical Industry·Stock Market

Healthcare stocks hold up as defensive bid lingers; Pfizer, Merck earnings set the tone

The Health Care Select Sector SPDR Fund, a popular collection of major U.S. healthcare stocks, ended Friday up roughly 0.6%, closing at $154.74. Nasdaq data indicated the fund carried a defensive bid into the weekend.

1 February 2026

Earnings·NYSE:ELV·NYSE:MRK·NYSE:PFE·NYSE:UNH·Pharmaceuticals

Merck stock jumps to $110 as MRK heads into a big earnings week

Merck & Company, Inc. shares closed Friday on an uptick, outperforming a weaker U.S. market and holding close to a recent high.

31 January 2026

Earnings Reports·NYSE:MRK·Pharmaceutical Industry·Stock Market

Healthcare stocks hold up as Lilly’s $3.5 billion plant plan hits tape; biotech bruised

Healthcare shares ended Friday stronger than the wider market following Eli Lilly’s announcement of a $3.5 billion manufacturing facility in Pennsylvania dedicated to injectable weight-loss drugs. CEO David Ricks described the new plant as “really state of the art manufacturing to last many decades to come” during a press briefing.

31 January 2026

HKG:1099·NYSE:AZN·NYSE:LLY·NYSE:MRK·NYSE:NVO·NYSE:PFE·Pharmaceuticals

Merck stock beats a falling market — here’s what investors watch before Feb. 3 earnings

Merck shares climbed 1.78% to $110.27 on Friday, edging the drugmaker to within roughly 2.3% of its 52-week peak despite a dip in the broader market. Volume hit about 19.1 million shares, surpassing its 50-day average, MarketWatch reported.

31 January 2026

Earnings Reports·NYSE:MRK·Stock Market

Previous 1 2 3 4 … 8 Next

Merck stock slides 3.5% as insider sale filing lands; traders eye next FDA deadline

Amgen stock drops nearly 2% as Dow drag builds — what AMGN investors watch next

Merck stock drops nearly 4%: why MRK is lagging the market today

Dow Jones Industrial Average slips under 50,000 as AI shakeout bites; payrolls, CPI loom

Merck stock is inches from a 52-week high — and an insider just sold shares

Merck stock ends week near highs after Canada clears ENFLONSIA; insider sales surface

Merck (MRK) stock price rises as Enflonsia approval and insider filing keep attention on what’s next

Merck stock rises 2% in New York as MRK traders size up outlook and a fresh RSV approval

Merck stock rises after-hours as cautious 2026 forecast meets new cholesterol pill headlines

Merck stock price rises today as MRK rallies on Keytruda strength despite soft 2026 outlook

Merck stock price rises after hours after choppy day — MRK traders focus on 2026 outlook and FDA dates

Dow Jones slips 167 points on AI disruption fears; Alphabet, Amazon earnings next

Merck stock rises despite cautious 2026 outlook as patent losses loom

Merck stock rises ahead of earnings: MRK traders eye guidance and the Keytruda cliff

Merck stock price ends higher ahead of Feb. 3 earnings — what MRK investors watch next week

Healthcare stocks hold up as defensive bid lingers; Pfizer, Merck earnings set the tone

Merck stock jumps to $110 as MRK heads into a big earnings week

Healthcare stocks hold up as Lilly’s $3.5 billion plant plan hits tape; biotech bruised

Merck stock beats a falling market — here’s what investors watch before Feb. 3 earnings

TechStock² Updates

Marvell shares fall 10.3% as Google AI-related revenue projected for fiscal 2029

SpaceX Shares Advance 0.5% as $18.4 Billion Capital Spending Outpaces Revenue

American Airlines Shares Edge Down 0.6% Despite Record Revenue, Yielding 0.4% Net Margin

IREN Shares Slide 12.5% as $30 Billion Capex Faces $4 Billion AI Revenue Pace

Disney Stock Rises 1.2% as Pokémon Deal Targets a $4.7 Billion Streaming Base

CME Group Shares Gain 1.7% as Record Trading Volume Lifts Margin to 69.5%

Lululemon Shares Rise 5.1% Despite Earnings Highlighting 410-Basis-Point Margin Decline

Chevron Shares Gain 1.1%, Market Cap Grows by $4.1 Billion as Venezuela Deal Approaches

SoFi Shares Slide 5.8% Despite 43% Revenue Gain as Sales Multiple Hits 4.9x

Plug Power Shares Drop 3.5% After Quarterly Cash Outflow Reduces $162 Million Reserve

Investment Disclaimer